"The Cymerus™ technology potentially enables mass production of mesenchymal stem cells that, subject to further testing, may be used to remedy a broad range of diseases including cardiovascular disease, diabetes, diseases of the blood, lung, kidney and immune system diseases."
Source: CYP ASX Announcement 26-11-13
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $40.67M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.0¢ | 17.5¢ | $23.71K | 131.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12500 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 86246 | 2 |
View Market Depth
| Last trade - 16.10pm 21/07/2025 (20 minute delay) ? |
| CYP (ASX) Chart |